Microparticles in Pediatric Inflammatory Disease
NCT00979485 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2011-06-23
Summary
The purpose of this study is to provide data correlating levels of microparticles that circulate in the blood and disease activity in children with inflammatory bowel disease (IBD). The hypothesis is that circulating microparticles will be higher in children with active IBD, show inflammatory activity, and will be low in patients in remission as well as in healthy controls.
Conditions
Sponsors & Collaborators
-
Indiana University
lead OTHER
Principal Investigators
-
Steven ' Steiner, MD · Indiana University
Eligibility
- Min Age
- 8 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- United States
Study Locations
More Related Trials
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease
NCT02566889 ·Status: TERMINATED ·Phase: PHASE4
-
Biofeedback in Pediatric Inflammatory Bowel Disease
NCT04269720 ·Status: WITHDRAWN ·Phase: NA
-
Targeted Metabolomics to Decipher Dietary Contributions to Pediatric Inflammatory Bowel Disease (IBD) - Main Study
NCT05014243 ·Status: UNKNOWN
-
Impact of Therapeutic Strategies in the Pediatric Inflammatory Bowel Disease: a Population Based Study (1988-2011).
NCT02392221 ·Status: COMPLETED
-
Top-down Infliximab Study in Kids With Crohn's Disease
NCT02517684 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)
NCT04223518 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
NCT03209232 ·Status: TERMINATED ·Phase: NA
-
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346 ·Status: ACTIVE_NOT_RECRUITING
-
Adjunctive Treatment With Vitamin D3 in Patients With Active IBD
NCT04225819 ·Status: SUSPENDED ·Phase: NA
-
Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD
NCT07121920 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
NCT00783575 ·Status: WITHDRAWN
-
The ImageKids Study: Developing the pMEDIC and the PICMI
NCT01881490 ·Status: COMPLETED ·Phase: NA
-
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
NCT03278912 ·Status: WITHDRAWN
-
A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease
NCT03478956 ·Status: TERMINATED ·Phase: PHASE1
-
Decoding Personalized Nutritional, Microbiome and Host Patterns Impacting Clinical and Prognostic Features in Crohn's Disease
NCT04283864 ·Status: ACTIVE_NOT_RECRUITING
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04987307 ·Status: TERMINATED ·Phase: PHASE2
-
Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD)
NCT04881370 ·Status: TERMINATED
-
Microbiota-targeted Diet for Pediatric UC
NCT02922881 ·Status: COMPLETED ·Phase: NA
-
Microplastic Analysis in Pediatric Inflammatory Bowel Disease
NCT07141238 ·Status: RECRUITING
-
The Inflammatory Bowel Disease - Anti-Inflammatory Diet (IBD-AID)
NCT04757181 ·Status: COMPLETED ·Phase: NA
-
Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
NCT02345733 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis
NCT03980405 ·Status: TERMINATED ·Phase: NA